BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8246328)

  • 1. High-resolution computed tomographic bronchiolography using perfluoroctylbromide (PFOB): an experimental model.
    Stern RG; Wolfson MR; McGuckin JF; Forge JA; Shaffer TH
    J Thorac Imaging; 1993; 8(4):300-4. PubMed ID: 8246328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfluoroctylbromide: a reticuloendothelial-specific and tumor-imaging agent for computed tomography.
    Mattrey RF; Long DM; Multer F; Mitten R; Higgins CB
    Radiology; 1982 Dec; 145(3):755-8. PubMed ID: 7146408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental comparison of EOE-13 and perfluoroctylbromide for the CT detection of hepatic metastases.
    Patronas N; Miller DL; Girton M
    Invest Radiol; 1984; 19(6):570-3. PubMed ID: 6096289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfluoroctylbromide as a blood pool contrast agent for liver, spleen, and vascular imaging in computed tomography.
    Mattrey RF; Long DM; Peck WW; Slutsky RA; Higgins CB
    J Comput Assist Tomogr; 1984 Aug; 8(4):739-44. PubMed ID: 6736376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfluoroctylbromide and hepatosplenic computed tomography. Preliminary clinical study.
    Bruneton JN; Falewee MN; Balu-Maestro C; Normand F; Mattrey RF
    Invest Radiol; 1988 Sep; 23 Suppl 1():S306-7. PubMed ID: 3198367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfluoroctylbromide as a contrast agent for computed tomographic imaging of septic and aseptic arthritis.
    Sartoris DJ; Guerra J; Mattrey RF; Resnick D; Haghighi P; Mitten R; Trudell D; Pate D
    Invest Radiol; 1986 Jan; 21(1):49-55. PubMed ID: 3943957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological disposition of perfluoroctylbromide: tracheal administration in alveolography and bronchography.
    Liu MS; Long DM
    Invest Radiol; 1976 SEP-OCT; 11(5):479-85. PubMed ID: 977265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of a perfluorochemical liquid for pulmonary diagnostic imaging.
    Wolfson MR; Stern RG; Kechner N; Sekins KM; Shaffer TH
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1409-20. PubMed ID: 7849952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor imaging effects of perfluoroctylbromide (PFOB) emulsion].
    Murata K; Itoh Y; Ayakawa Y; Miyata N
    Nihon Gan Chiryo Gakkai Shi; 1988 Dec; 23(11):2669-78. PubMed ID: 3249107
    [No Abstract]   [Full Text] [Related]  

  • 10. Specific enhancement of intra-abdominal abscesses with perfluoroctylbromide for CT imaging.
    Mattrey RF; Andrè M; Campbell J; Mitten R; Multer F; Hackney D; Long DM; Higgins CB
    Invest Radiol; 1984; 19(5):438-46. PubMed ID: 6511250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Imaging of tumor, liver and spleen with computed tomography (CT) using perfluoroctylbromide emulsion (PFOB)].
    Murata K
    Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):104-13. PubMed ID: 3379326
    [No Abstract]   [Full Text] [Related]  

  • 12. Perfluoroctylbromide: a liver/spleen-specific and tumor-imaging ultrasound contrast material.
    Mattrey RF; Scheible FW; Gosink BB; Leopold GR; Long DM; Higgins CB
    Radiology; 1982 Dec; 145(3):759-62. PubMed ID: 7146409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gas exchange and lung mechanics during high frequency ventilation in the perflubron-treated lung.
    Wolf GK; Sheeran P; Heitz D; Thompson JE; Arnold JH
    Pediatr Crit Care Med; 2008 Nov; 9(6):641-6. PubMed ID: 18838935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtual bronchoscopy with perfluoronated hydrocarbon enhancement.
    Milestone BN; Miller T; Wolfson MR; Stern RG; Shaffer TH
    Acad Radiol; 1997 Aug; 4(8):583-6. PubMed ID: 9261458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution CT findings in patients with near-fatal asthma: comparison of patients with mild-to-severe asthma and normal control subjects and changes in airway abnormalities following steroid treatment.
    Lee YM; Park JS; Hwang JH; Park SW; Uh ST; Kim YH; Park CS
    Chest; 2004 Dec; 126(6):1840-8. PubMed ID: 15596682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose response to aerosolized perflubron in a neonatal swine model of lung injury.
    Kandler MA; von der Hardt K; Gericke N; Chada M; Dötsch J; Rascher W
    Pediatr Res; 2004 Aug; 56(2):191-7. PubMed ID: 15181181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfluoroctylbromide. Acute hemodynamic effects, in pigs, of intravenous administration compared with the standard ionic contrast media.
    Peck WW; Mattrey RF; Slutsky RA; Higgins CB
    Invest Radiol; 1984; 19(2):129-32. PubMed ID: 6533103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of positive end-expiratory pressure, tidal volume and perflubron doses on gas exchange during partial liquid ventilation].
    Takeuchi C; Nakazawa K; Yokoyama K; Matsuzawa Y; Makita K
    Masui; 2001 Feb; 50(2):116-21. PubMed ID: 11244763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Typical findings for bronchiolitis in high resolution computed tomography.
    Pasławski M; Krzyzanowski K; Złomaniec J
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):32-7. PubMed ID: 16145951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfluoroctylbromide as a gastrointestinal contrast agent for MR imaging: use with and without glucagon.
    Brown JJ; Duncan JR; Heiken JP; Balfe DM; Corr AP; Mirowitz SA; Eilenberg SS; Lee JK
    Radiology; 1991 Nov; 181(2):455-60. PubMed ID: 1924788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.